Intraoperative estimation of intraocular lens power

Information

  • Patent Grant
  • 7988291
  • Patent Number
    7,988,291
  • Date Filed
    Tuesday, July 7, 2009
    15 years ago
  • Date Issued
    Tuesday, August 2, 2011
    13 years ago
Abstract
Apparatus for performing intraocular implant surgery, including surgical apparatus for performing intraocular implant surgery, an autorefraction device associated with the surgical apparatus, wherein the autorefraction device is configured to perform autorefraction on the aphakic eye to provide one or more aphakic refraction measurements, and a processor connected to the autorefraction device, wherein the processor is configured to process the aphakic refraction measurements and provide the user of the apparatus with information regarding the power of the intraocular lens.
Description
TECHNICAL FIELD

This invention relates to methods and apparatus for selecting the power of an intraocular lens to be implanted into an eye.


BACKGROUND

The history of intraocular lens implantation dates back to 1949 when an initial attempt to replace a diseased lens with an artificial one resulted in a poor outcome with an error of −24.0 diopter (D). Nevertheless, this set the stage for continuous advances in the field of ophthalmology, leading to the common practice of “standard-of-care” lens implantation we see today. The technology of cataract surgery has witnessed an impressive development through constant innovation of surgical technique and instrumentation, lens material and design, and just as importantly, ever improving methodology for calculating and predicting the power of the lens implant necessary to achieve desired postoperative refractive outcome. In the 1960s Fyodorov was the first scientist to publish a formula for predicting the power of the intraocular lenses (IOLs) based on geometrical optics incorporating two very important preoperative anatomical parameters of the ocular system. A-scan derived axial length of the eye and keratometry measurements of the cornea, Feodorov S N, Kolinko A L. Estimation of optical power of the intraocular lens. Vestn. Oftamol; 80(4):27-31 (1967). Colenbrander published the first formula written in English in 1973. Colenbrander, Calculation of the Power of an Iris-Clip Lens for Distance Vision, Br. J. Ophthal. 57:735-40 (1973). Many further improvements followed these pioneering efforts. Binkhorst described a derivative formula in the 1970s. Binkhorst R D., The optical design of intraocular lens implants. Ophthalmic Surg 1975;6(3):17-31. Binkhorst, Power of the Pre-Pupillary Pseudoshakos, B.J.O. 56:332-37, (1972)). Modifications of the Colenbrander formula were implemented by Dr. Hoffer with further improvement of accuracy across the different axial length ranges. Hoffer K J. Mathematics and computers in intraocular lens calculation. Am Intra-Ocular Implant Soc J 1975; 1(1):4-5). In 1980, Sanders, Retzlaff and Kraff derived a regression formula which has sustained many subsequent updates and modifications. Further refinements were achieved with the second generation formulas which had better precision over a wider range of anatomic parameters, but all used axial length and corneal curvature (keratometry) as the main predictive variable in their models. Sanders, J. Retzlaff & M. C. Kraff, Comparison of the SRK II Formula and the Other Second Generation Formulas, J. Cataract & Refractive Surg. 14(3):136-41 (1988). Olsen, T., Theoretical Approach to IOL Calculation Using Gaussian Optics, J. Cataract & Refractive Surg. 13:141-45 (1987). Holladay, T. C. Praeger, T. Y. Chandler & K. H. Musgrove, A Three-Party System for Refining Intraocular Lens Power Calculations, J. Cataract & Refractive Surg. 14:17-24 (1988). J. T. Thompson, A. E. Maumenee & C. C. Baker, A New Posterior Chamber Intraocular Lens Formula for Axial Myopes, Ophthal. 91:484-88 (1984). Various improvements in making preoperative anatomic-based estimates of IOL power have been described in the patent literature (e.g., U.S. Pat. Nos. 6,634,751, 5,968,095, and 5,282,852).


The shortcomings of current technology are multifold. Even in the ideal and most simplified clinical setting, about 10-20% of patients remain with at least 1.0 diopter refractive error after surgery. In about 3-5% of cases this residual can be as high as 2 diopters. Also, traditional IOL estimation techniques based on axial length and corneal curvature produce even greater inaccuracy when the cataract surgery is done after vision correcting refractive surgery (e.g., Lasik, Lasek, wavefront and other similar corrective procedures). In this setting, a larger residual error can result (e.g., more than about 80% of such cases have about 1-1.5 diopter error). Reliance on anatomic measurements is even more problematic for a patient whose eye shape is at the extreme end of the range of an anatomic parameter.


Autoretinoscopy has been traditionally used for determination of the optical state of the ocular system in an office visit. In this office setting, autoretinoscopy is used as an objective measurement to guide the subjective testing and estimation of the power for corrective eye glass prescription. In this setting, an autorefractor based on the principle of automated retinoscopy, is used with the eye in the phakic state (i.e., with the native lens in its native position). A number of widely available autoretinoscopes are employed with the patient in a sitting position in front of the apparatus.


In recent years, very significant advances have been made in IOL surgical techniques and instrumentation (e.g., microincision techniques for quick and controlled cataract surgery), but IOL power has continued to be estimated preoperatively using anatomic measurements.


SUMMARY

The problems associated with current methods for IOL power estimation lie in the reliance on preoperative measurements, e.g., corneal curvature and axial length. These parameters can change significantly after the eye has been manipulated. For example, the curvature of the cornea and its optical properties change after incisions and intraocular procedures. Current models extrapolate the effective lens position of the implant through lens-associated constants, such as the A-constant, which are inherent to the specific lens design, but not to the particular anatomy of each eye, and therefore not individually customized to each surgical case. The current methods, because they only approximate the optical deficiency of the eye after lens extraction, lead to residual errors in lens power.


In a first aspect, the invention features a method for selecting the power of an intraocular lens, comprising extracting the native lens, performing autorefraction on the aphakic eye to provide one or more aphakic refraction measurements, and determining the power of the intraocular lens from the one or more aphakic refraction measurements.


Preferred implementations of this aspect of the invention may incorporate one or more of the following. The autorefraction may be performed with the patient in the same position in which the native lens was extracted. The position of the patient may be the supine position. The method may be used for patients that have previously undergone vision correcting refractive surgery. Determining the power of the intraocular lens may comprise using a predictive model that is an empirically derived relationship between the autorefraction measurements and the power of the intraocular lens. Determining the power of the intraocular lens may comprise using a predictive model that is a theoretically derived relationship between the autorefraction measurements and the power of the intraocular lens. The native lens may be extracted using a surgical microscope and the autorefraction may be performed using an autorefraction device configured to be moved into place for making autorefraction measurements following extraction of the native lens using the surgical microscope. The autorefraction may comprise making a plurality of autorefraction measurements and averaging the measurements. Determining the power of the intraocular lens may comprise determining the power from the one or more autorefractive measurements and from other parameters. The other parameters may include preoperative anatomic measurements of the eye. They may also include one or more of the following: intraocular pressure, intraoperative axial length, intraoperative keratometry, preoperative keratometry, preoperative axial length, intraoperative anterior chamber depth, or preoperative anterior chamber depth.


In a second aspect, the invention features apparatus for performing intraocular implant surgery, comprising surgical apparatus for performing intraocular implant surgery, an autorefraction device associated with the surgical apparatus, wherein the autorefraction device is configured to perform autorefraction on the aphakic eye to provide one or more aphakic refraction measurements, and a processor connected to the autorefraction device, wherein the processor is configured to process the aphakic refraction measurements and provide the user of the apparatus with information regarding the power of the intraocular lens.


Preferred implementations of this aspect of the invention may incorporate one or more of the following. The apparatus may further comprise a display for providing the user of the apparatus with the information regarding the power of the intraocular lens. The autorefraction device may be attached to or integrated with the surgical apparatus. The surgical apparatus may be a surgical microscope and the autorefraction device may comprise an autorefraction device configured to be moved into place for making refraction measurements following extraction of the native lens using the surgical microscope. The autorefraction device may be a portable autorefraction device that is used while a patient is in the supine position following surgical extraction of the lens. The autorefraction device may comprise a retinoscope. The autorefraction device may comprise a wavefront-based autorefraction device. The autorefraction device may comprise apparatus for measuring the aphakic dioptric state, the deficiency of the ocular system, or both the aphakic dioptric state and the deficiency of the ocular system. The autorefraction device may comprise or work in combination with an external lens, contact lens, intraocular lens, or other component with refractive or medium properties positioned along the optical axis along an autorefraction measurement trajectory. The surgical apparatus may comprise a surgical microscope that includes an ocular piece or display for centration and positioning and a toggle for XYZ movement, and wherein the autorefraction device may be positioned and configured so that movement of the toggle can adjust the position of the autorefraction device relative to the eye.


Among the many advantages of the invention (some of which may be achieved only in some of its various aspects and implementations) are the following: Greater precision is possible in estimating required IOL power, and thus there is less residual refractive error. It is possible to achieve reductions in the complexity and cost associated with IOL implantation surgery (e.g., it may be possible to eliminate the need for expensive equipment such as an A-scan biometry device and a keratometer, as well as the need for a separate pre-operative patient visit at which pre-operative eye measurements are made). The invention makes it possible to break away from the conventional preoperative anatomical approaches derived from Feodorov's original work in 1967. New refractive measurement technology can be used to predict the power of the intraocular lens. Anatomic parameters such as preoperative axial length and keratometry are no longer essential to the process of estimating the power of the intraocular lens (but these parameters, as well as others, may, in some implementations, be used in combination with the intraoperative autorefraction measurements). Relying on intraoperative measurement of the aphakic refractive state of the eye after lens extraction has the advantage that it measures the optical deficiency of the ocular system without the confounding interference of the native lens. Modern retinoscopy technology can be adapted to cataract surgery immediately after extraction of the cataract, when the eye is transiently aphakic; in this state, the cornea is the primary refractive medium and the optical system of the eye is in a unique state of non-interference by the lenticular optical component. When an autorefraction or other form of retinoscopy is done before a lens is implanted, the measurements are primed to correlate closely with the missing intraocular lens power. From these measurements the surgeon one can derive, correlate and calculate the parameters of the lens to be inserted. The method can be used solely for the purposes described or in combination with other ocular measurements and parameters obtained prior or during surgery to optimize accuracy and precision.


Other features and advantages of the invention will be found in the detailed description, drawings, and claims.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is flow chart of steps in one implementation of the invention.



FIG. 2 is a diagrammatic view of apparatus implementing the invention in pone possible manner.





DETAILED DESCRIPTION

There are a great many possible implementations of the invention, too many to describe herein. Some possible implementations that are presently preferred are described below. It cannot be emphasized too strongly, however, that these are descriptions of implementations of the invention, and not descriptions of the invention, which is not limited to the detailed implementations described in this section but is described in broader terms in the claims.



FIG. 1 shows the process followed in one implementation of the invention. Any surgical technique for lens extraction may be used, including such conventional techniques as phacoemulsification or extracapsular cataract extraction. After the lens is extracted from the eye and all particulate lens material is removed, the anterior chamber is maintained formed with intraocular fluid or viscoelastic. The eye is then centered and an autorefracting device is used to obtain a refractive reading of the aphakic eye (i.e., the eye with the lens removed). While any autorefractor can be used across a wide range of possible vertex distances, one possible implementation is to use an autorefractor with a vertex distance of 13.75 mm, and to take an average of multiple autorefraction measurements. Autorefraction provides a spherical and a cylindrical power measurement.


The power of the intraocular lens can be derived from the refraction measurements. One possible method for deriving the intraocular lens power is to use an empirically derived relationship, which could be called a predictive IOL model, that relates the refraction measurements to the IOL power. This can be done, for example, by first calculating the aphakic spherical equivalent of the refraction measurements from the standard formula:

Spherical Equiv=Measured Spherical Power+½ Measured Cylindrical Power,

wherein Spherical Equiv is the aphakic spherical equivalent, Measured Spherical Power is the average of the spherical power measurements made using autorefraction, and Measured Cylindrical Power is the average of the cylindrical power measurements made using autorefraction. Next, the following empirically derived relationship may be used to relate the aphakic spherical equivalent to the IOL power:

IOL Power=A+c+b*(Spherical Equiv),

wherein A is the lens specific constant (and depends on the type of intraocular lens being implanted), c is an empirically derived constant, and b is the empirically derived linear correlation coefficient.


The two empirically derived coefficients c, b may be derived using a statistical regression analysis of data relating IOL power to autorefraction measurement of the spherical equivalent. For example, the regression analysis may be performed on data collected from a large population of patients (e.g., one hundred patients). For each patient, the data comprise the IOL Power selected using conventional preoperative measurements and the spherical equivalent from an intraoperative autorefraction.


Other relationships between the refraction measurements and the IOL power may also be used, and the necessary constants and coefficients derived either empirically or theoretically. One alternative, of course, is to simply combine the two formulas as follows:

IOL Power=A+c+b*(Measured Spherical Power+½ Measured Cylindrical Power),

Varying the vertex distance of autorefraction or modifying the optical media along the optical path (e.g., by inserting a different material into the anterior chamber of the eye, or by placing a temporary lens in or near the eye) can alter the parametric variables of the relationship.


In some implementations, the above formulation can be improved with additional variables to achieve better precision. Parameters such as intraocular pressure, intraoperative axial length, intraoperative keratometry, preoperative keratometry, preoperative axial length, intra and preoperative anterior chamber depth can be used as supplementary correlates in the predictive model, in order to refine the IOL power. For example, the following relationship could be used:

IOL Power=A+c+b*(Spherical Equiv)+d*(Axial Length)+f*(Average Keratometry)+g*(Intraoperative Pressure)


In one implementation, both the surgery and the autorefraction are performed using standard available equipment. A standard surgical microscope is used for extraction of the native lens, and a standard portable autorefraction device (e.g., a Nikon Retinomax) is used for autorefraction. Both procedures may be performed while the patient remains in the same supine position. The refraction measurements are read from the autorefraction device, and the IOL power is calculated using a formula such as one of those given above.



FIG. 2 shows another possible implementation in which specially designed equipment is used. An autorefraction retinoscope unit 10 is attached to the exterior of an ophthalmic surgical microscope 12. The surgical microscope in this implementation has its own display for centration and visualization. A toggle control 13 (and/or a pedal control) is provided for XYZ centration of the microscope and the retinoscope unit. The microscope has the usual lens array 15. The autorefraction unit can be a conventional automated retinoscopic apparatus of the type conventionally used to measure the dioptric deficiency and optical state of the phakic eye. The retinoscopic apparatus would be configured to operate with the patient in the supine position, intraoperatively, and to be moved out of the way of the microscopic surgical device when not in use, but configured so that its position and orientation is adjustable using the toggle control 13. A display unit 14 is integrated with the autorefraction unit 10 and also attached to the surgical microscope 12. The display unit presents the results of the IOL power determination. A processing unit 16 is electrically connected to the autorefraction unit and the display. Cables 18 make the electrical connections between the autorefraction unit 10, display unit 14, and processing unit 16. The processing unit receives measurement data from the autorefraction unit, and uses a predictive model (e.g., one of those described by the above formulas) to calculate the IOL power for display on the display unit.


An alternative to the arrangement shown in FIG. 2 would be to have the autorefraction unit, display unit, and processing unit fully integrated into the ophthalmic surgical microscope. For example, the same display unit can serve both for centration and visualization during surgery and for controlling and displaying results from the autorefraction unit and processing unit during IOL power determination.


The equipment of FIG. 2 or alternative implementations may be used to perform the eye surgery, to make the intraoperative refraction measurement, and to calculate the IOL power for achieving the desired emmetropia or postoperative refraction.


Many other implementations of the invention other than those described above are within the invention, which is defined by the following claims. For example, as earlier noted, completely separate surgical and autorefraction equipment may be used (e.g., with the microscope moved away, and the autorefraction equipment moved into place), and the IOL measurement may be calculated from the refraction measurements without using a special processor or display unit. Autorefraction may also be used after the intraocular lens is implanted (pseudophakic eye), to confirm whether a satisfactory choice has been made for the IOL power. If the autorefraction shows a residual error, the surgeon could immediately remove the implanted lens, and substitute another. Various types of autorefraction may be used to make the intraoperative refraction measurement of the aphakic eye.

Claims
  • 1. Apparatus for performing intraocular implant surgery, comprising: a surgical apparatus for performing intraocular implant surgery;an autorefraction device associated with the surgical apparatus, wherein the autorefraction device is configured to perform autorefraction on the aphakic eye following extraction of the native lens, to provide one or more aphakic refraction measurements; anda processor connected to the autorefraction device, wherein the processor is configured to process the aphakic refraction measurements and provide the user of the apparatus with information regarding the power of the intraocular lens, and wherein the processor uses a predictive model that provides a relationship between the autorefraction measurements and the power of the intraocular lens.
  • 2. The apparatus of claim 1 further comprising a display for providing the user of the apparatus with the information regarding the power of the intraocular lens.
  • 3. The apparatus of claim 1 wherein the autorefraction device is attached to or integrated with the surgical apparatus.
  • 4. The apparatus of claim 3 wherein the surgical apparatus is a surgical microscope and the autorefraction device comprises an autorefraction device configured to be moved into place for making refraction measurements following extraction of the native lens using the surgical microscope.
  • 5. The apparatus of claim 1 wherein the autorefraction device is a portable autorefraction device that is configured to be used with the surgical apparatus while the patient is in a surgical position following surgical extraction of the lens.
  • 6. The apparatus of claim 1 wherein the autorefraction device comprises a retinoscope.
  • 7. The apparatus of claim 1 wherein the autorefraction device comprises a wavefront-based autorefraction device.
  • 8. The apparatus of claim 1 wherein the autorefraction device comprises an apparatus for measuring the aphakic dioptric state, the deficiency of the ocular system, or both the aphakic dioptric state and the deficiency of the ocular system.
  • 9. The apparatus of claim 1 wherein the autorefraction device comprises or works in combination with an external lens, contact lens, intraocular lens, or other component with refractive or medium properties positioned along the optical axis along an autorefraction measurement trajectory.
  • 10. The apparatus of claim 1 wherein the surgical apparatus comprises a surgical microscope that includes an ocular piece or display for centration and positioning and a control for XYZ movement, and wherein the autorefraction device is positioned and configured so that the control can adjust the position of the autorefraction device relative to the eye.
  • 11. The apparatus of claim 1 wherein the power of the intraocular lens comprises one or both of a spherical power and a cylindrical power.
  • 12. The apparatus of claim 1 wherein the surgical apparatus is a surgical microscope.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional application of and claims priority to U.S. application Ser. No. 10/820,635, filed on Apr. 8, 2004 now U.S. Pat. No. 7,556,378. This application also claims priority to U.S. Provisional Application Ser. No. 60/461,429, filed on Apr. 10, 2003. The disclosures of the prior applications are considered part of (and are incorporated by reference in) the disclosure of this application.

US Referenced Citations (187)
Number Name Date Kind
4125320 Rassow Nov 1978 A
4172662 Vogel Oct 1979 A
4173398 Okamoto et al. Nov 1979 A
4293198 Kohayakawa et al. Oct 1981 A
4353625 Nohda et al. Oct 1982 A
4372655 Matsumura et al. Feb 1983 A
4376573 Matsumura et al. Mar 1983 A
4390255 Nohda et al. Jun 1983 A
4421391 Matsumura et al. Dec 1983 A
4459027 Kafri et al. Jul 1984 A
4541697 Ramijan Sep 1985 A
4640596 Humphrey Feb 1987 A
4650301 Humphrey Mar 1987 A
4669835 Humphrey Jun 1987 A
4692003 Adachi et al. Sep 1987 A
4710193 Volk Dec 1987 A
4721379 L'Esperance Jan 1988 A
4730917 Krueger Mar 1988 A
4911711 Telfair et al. Mar 1990 A
4964715 Richards Oct 1990 A
4984883 Winocur Jan 1991 A
4995716 Warnicki et al. Feb 1991 A
5080477 Adachi Jan 1992 A
5157427 Humphrey Oct 1992 A
5164750 Adachi Nov 1992 A
5206672 Rowe Apr 1993 A
5208619 Campbell May 1993 A
5223863 Heine Jun 1993 A
5252999 Sukigara Oct 1993 A
5258791 Penny et al. Nov 1993 A
5270749 Okumura Dec 1993 A
5282852 Capetan et al. Feb 1994 A
5294971 Braunecker et al. Mar 1994 A
5307097 Baker Apr 1994 A
5329322 Yancey Jul 1994 A
5374193 Trachtman Dec 1994 A
5450143 Rowe et al. Sep 1995 A
5455645 Berger et al. Oct 1995 A
5493109 Wei et al. Feb 1996 A
5576780 Yancey Nov 1996 A
5777719 Williams et al. Jul 1998 A
5796463 Bullimore Aug 1998 A
5800533 Eggleston et al. Sep 1998 A
5861937 Fujieda Jan 1999 A
5909268 Isogai et al. Jun 1999 A
5936706 Takagi Aug 1999 A
5949521 Williams et al. Sep 1999 A
5963300 Horwitz Oct 1999 A
5968095 Norrby Oct 1999 A
5994687 Chanteloup et al. Nov 1999 A
6002484 Rozema et al. Dec 1999 A
6004313 Shimmick et al. Dec 1999 A
6007204 Fahrenkrug et al. Dec 1999 A
6042232 Luce et al. Mar 2000 A
6043885 Mazuet et al. Mar 2000 A
6050687 Bille et al. Apr 2000 A
6086204 Magnante Jul 2000 A
6095651 Williams et al. Aug 2000 A
6096077 Callahan et al. Aug 2000 A
6155684 Bille et al. Dec 2000 A
6199986 Williams et al. Mar 2001 B1
6251101 Glockler Jun 2001 B1
6262328 Wicks et al. Jul 2001 B1
6264328 Williams et al. Jul 2001 B1
6270221 Liang et al. Aug 2001 B1
6271915 Frey et al. Aug 2001 B1
6275718 Lempert Aug 2001 B1
6299311 Williams et al. Oct 2001 B1
6299618 Sugiura Oct 2001 B1
6338559 Williams et al. Jan 2002 B1
6379005 Williams et al. Apr 2002 B1
6382793 Lai et al. May 2002 B1
6382794 Lai et al. May 2002 B1
6382795 Lai May 2002 B1
6394605 Campin et al. May 2002 B1
6409345 Molebny et al. Jun 2002 B1
6419671 Lemberg Jul 2002 B1
6439720 Graves et al. Aug 2002 B1
6460997 Frey et al. Oct 2002 B1
6497483 Frey et al. Dec 2002 B2
6508812 Williams et al. Jan 2003 B1
6550917 Neal et al. Apr 2003 B1
6570143 Neil et al. May 2003 B1
6572230 Levine Jun 2003 B2
6575572 Lai et al. Jun 2003 B2
6578963 Pettit Jun 2003 B2
6585723 Sumiya Jul 2003 B1
6588902 Isogai Jul 2003 B2
6598975 Liang et al. Jul 2003 B2
6601956 Jean et al. Aug 2003 B1
6609793 Norrby et al. Aug 2003 B2
6609794 Levine Aug 2003 B2
6626535 Altmann Sep 2003 B2
6626538 Arrowsmith Sep 2003 B1
6634751 Turner et al. Oct 2003 B2
6637884 Martino Oct 2003 B2
6658282 Eagan et al. Dec 2003 B1
6679606 Campin et al. Jan 2004 B2
6685319 Watson et al. Feb 2004 B2
6702806 Gray et al. Mar 2004 B2
6705729 Piers et al. Mar 2004 B2
6736509 Martino et al. May 2004 B2
6736510 Van Heugten May 2004 B1
6739721 Altmann May 2004 B2
6761454 Lai et al. Jul 2004 B2
6781681 Horwitz Aug 2004 B2
6786603 Altmann Sep 2004 B2
6793654 Lemberg Sep 2004 B2
6827444 Williams et al. Dec 2004 B2
6836374 Esch et al. Dec 2004 B2
6905641 Platt et al. Jun 2005 B2
6908196 Herekar et al. Jun 2005 B2
6926710 Cox et al. Aug 2005 B2
6948818 Williams et al. Sep 2005 B2
6997555 Dick et al. Feb 2006 B2
7018376 Webb Mar 2006 B2
7034949 Horwitz Apr 2006 B2
7044602 Chernyak May 2006 B2
7044604 Arrowsmith May 2006 B1
7057806 Atkinson Jun 2006 B2
7066928 Dick et al. Jun 2006 B2
7068439 Esch et al. Jun 2006 B2
7070276 Koretz Jul 2006 B2
7077522 Williams Jul 2006 B2
7111938 Andino et al. Sep 2006 B2
7182780 Terwee et al. Feb 2007 B2
7255442 Bucourt et al. Aug 2007 B2
7303281 Wakil et al. Dec 2007 B2
7336371 Haidner et al. Feb 2008 B1
7341348 Eagan Mar 2008 B2
7350920 Levine Apr 2008 B2
7357509 Williams et al. Apr 2008 B2
7377641 Piers et al. May 2008 B2
7380942 Molebny et al. Jun 2008 B2
7401919 Vogelsang et al. Jul 2008 B2
7406263 Graves et al. Jul 2008 B2
7416305 Williams et al. Aug 2008 B2
7425067 Warden et al. Sep 2008 B2
7448752 Levine Nov 2008 B2
7455407 Neal et al. Nov 2008 B2
7467869 Kahlen Dec 2008 B2
7476248 Harris et al. Jan 2009 B2
7490938 Latkany Feb 2009 B2
7490940 Lai et al. Feb 2009 B2
7517087 Dick et al. Apr 2009 B2
7543937 Piers et al. Jun 2009 B2
7556378 Ianchulev Jul 2009 B1
20010041884 Frey et al. Nov 2001 A1
20020016629 Sandstedt et al. Feb 2002 A1
20020082629 Cox et al. Jun 2002 A1
20020105617 Norrby et al. Aug 2002 A1
20020107567 Terwee et al. Aug 2002 A1
20020118349 Yang et al. Aug 2002 A1
20020135736 Stark et al. Sep 2002 A1
20020154272 Shevlin Oct 2002 A1
20020158508 Watanabe Oct 2002 A1
20020163623 Hirohara et al. Nov 2002 A1
20030007127 Levine Jan 2003 A1
20030009156 Levine Jan 2003 A1
20030025080 Sting et al. Feb 2003 A1
20030174281 Herekar et al. Sep 2003 A1
20030223037 Chernyak Dec 2003 A1
20030230710 Wolleschensky et al. Dec 2003 A1
20040088050 Norrby et al. May 2004 A1
20040156014 Piers et al. Aug 2004 A1
20040167622 Sunalp et al. Aug 2004 A1
20040176753 Dick et al. Sep 2004 A1
20040189938 Eagan Sep 2004 A1
20040223214 Atkinson Nov 2004 A1
20040263785 Chernyak Dec 2004 A1
20050105044 Warden et al. May 2005 A1
20050117117 Bourla Jun 2005 A1
20050203422 Wei Sep 2005 A1
20050225725 Warden et al. Oct 2005 A1
20050241653 Van Heugten Nov 2005 A1
20050243276 Van Heugten et al. Nov 2005 A1
20050251115 Cox et al. Nov 2005 A1
20050278004 Steinert et al. Dec 2005 A1
20080231809 Haigis Sep 2008 A1
20090002628 Williams et al. Jan 2009 A1
20090036980 Norrby et al. Feb 2009 A1
20090103050 Michaels Apr 2009 A1
20090109401 Van Heugten Apr 2009 A1
20090164007 Van Heugten Jun 2009 A1
20100030225 Ianchulev Feb 2010 A1
20100036386 Ianchulev Feb 2010 A1
20100042210 Ianchulev Feb 2010 A1
Foreign Referenced Citations (26)
Number Date Country
0931504 Jul 1999 EP
138282 Jul 2004 IL
11-24434 May 1989 JP
9-122075 May 1997 JP
10-272100 Oct 1998 JP
2000-139996 May 2000 JP
2001-507258 Jun 2001 JP
2001-314372 Nov 2001 JP
2002-306418 Oct 2002 JP
2003-509731 Mar 2003 JP
2003-102689 Apr 2003 JP
WO 9201417 Feb 1992 WO
WO 9622506 Jul 1996 WO
WO 9827863 Jul 1998 WO
WO 0106914 Feb 2001 WO
WO 0121061 Mar 2001 WO
WO 0126591 Apr 2001 WO
WO 0158339 Aug 2001 WO
WO 0217775 Mar 2002 WO
WO 03002047 Jan 2003 WO
WO 03039356 May 2003 WO
WO 03050472 Jun 2003 WO
WO 03102498 Dec 2003 WO
WO 2004093663 Nov 2004 WO
WO 2005057252 Jun 2005 WO
WO 2006081031 Aug 2006 WO
Related Publications (1)
Number Date Country
20100030225 A1 Feb 2010 US
Provisional Applications (1)
Number Date Country
60461429 Apr 2003 US
Divisions (1)
Number Date Country
Parent 10820635 Apr 2004 US
Child 12499079 US